EAACI Launches Vision Zero to Combat Allergies and Asthma

The European Academy of Allergy and Clinical Immunology (EAACI) has launched “Vision Zero,” a global health initiative aiming to eliminate the burden of allergies and asthma. This ambition will serve as the central theme for the EAACI annual congress in Istanbul, Turkey, from June 12 to 15, 2026, according to the organization.

Why is the EAACI prioritizing “Vision Zero”?

Allergic diseases currently affect hundreds of millions of people globally and place increasing pressure on healthcare systems, according to the EAACI. The organization states these chronic conditions impact more than just health, affecting education, productivity, quality of life, and mental well-being.

EAACI President María Torres stated that “Vision Zero” represents a determination to move beyond disease management toward prevention. Torres noted that current scientific progress provides the basis for this ambition, provided there is collaboration between research, clinical practice, and public health.

Did You Know? The 2026 EAACI Congress will take place in Istanbul, Turkey, a city described by the organization as a crossroads between Europe and Asia, chosen to facilitate international collaboration.

What scientific advancements will be discussed?

The congress will feature research and clinical developments in precision medicine and immunotherapy, according to the EAACI. Experts will also examine digital health technologies and the roles of genetic and environmental factors in allergy development.

EAACI 2026 Istanbul: Vision Zero – A Future Free from Allergy & Asthma Burden

André Moreira, EAACI Vice-President of Congresses, stated the initiative encourages the allergology community to create healthier environments for future generations. The event will also address health equity to ensure these advancements are accessible to patients worldwide.

Expert Insight: Samantha Carter notes that the pivot from “management” to “prevention” suggests a strategic shift in how chronic respiratory conditions are framed. By targeting environmental and genetic triggers, the medical community may be attempting to lower the long-term societal costs associated with lost productivity and healthcare strain.

What happens next for allergy and asthma care?

The EAACI believes that coordinated political action and scientific innovation could significantly reduce the impact of these diseases on families and society. A possible next step involves the implementation of the preventive strategies discussed at the Istanbul congress.

If scientific discoveries are paired with effective implementation and political support, the burden of allergies and asthma may be considerably lightened over the long term, according to the organization’s vision.

Frequently Asked Questions

What is the goal of “Vision Zero”?
The initiative aims for a future free from the burden of allergies and asthma by shifting the focus from treating diseases to preventing them and reducing their impact.

When and where is the EAACI 2026 Congress?
The event will be held in Istanbul, Turkey, from June 12 to 15, 2026.

What areas of research will the congress highlight?
According to the EAACI, the event will focus on immunotherapy, precision medicine, digital health technologies, environmental and genetic factors, and preventive approaches.

How do you think a global shift toward allergy prevention would change daily life for future generations?